A coalition of US lawmakers is urging the Trump administration to prevent American companies from acquiring memory chips produced by ChangXin Memory Technologies (CXMT), a Chinese semiconductor manufacturer flagged by the Pentagon as linked to military activities.

Legislators’ Concerns

The push against CXMT comes as Apple has been lobbying for approval since May 2026 to purchase DRAM chips from the company. This situation has escalated from a routine supply chain decision to a significant national security issue. Representative John Moolenaar has voiced strong opposition, suggesting that sourcing components from a company associated with the Chinese military would inadvertently bolster Chinese capabilities.

The implications extend beyond the immediate chip procurement. Lawmakers are alarmed about potential revenue flowing to CXMT, which could ultimately support China's advancements in artificial intelligence and defense sectors.

Administrative Actions and Market Implications

In 2025, various US agencies reportedly moved to include CXMT on the Commerce Department’s Entity List, which would severely limit its transactions with American firms. However, the Trump administration has hesitated to finalize this decision, citing concerns about aggravating US-China relations amid rising tensions.

Meanwhile, CXMT is also eyeing an IPO on the Shanghai exchange, aiming for approximately $9.8 billion in proceeds. This would position the company to significantly enhance its manufacturing capabilities, further altering the dynamics of the global DRAM market, which is primarily controlled by Samsung, SK Hynix, and Micron. With CXMT now holding an 8% market share, this growth trajectory could disrupt established pricing structures.

For Apple, securing access to cost-effective Chinese DRAM is critical for managing production costs, especially as the demand for AI-driven memory increases. If denied access, the company may face higher expenses, which could impact its financial performance. In contrast, US firms like Micron might see increased opportunities should a ban on CXMT purchases be implemented.

This material is informational and should not be considered financial advice.